BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  How to Set Achievable Short Term Career Goals

  Short term career goals can ladder up into your long-term goals, but they are also likely more attainable. Here are some useful tips on how you can set them.

  December 13, 2019

   · 

  2 min read

   · 

  Laura Brothers
• 

  FDA

  FDA Approves Pfizer’s Extended Release Xeljanz for Ulcerative Colitis

  The FDA approved extended-release 11 mg and 22 mg tablets as a once-daily treatment from the chronic inflammatory condition.

  December 13, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Pelosi Drug Pricing Reform Bill Moves to the Senate Following Approval in the House

  House Speaker Nancy Pelosi’s drug pricing reform bill passed the House of Representatives in a mostly party-line vote and will now head to the U.S. Senate, where its chances of moving forward in the Republican-led chamber are slim.

  December 13, 2019

   · 

  3 min read

   · 

  Alex Keown
• 

  Job Trends

  Clinical Catch-Up: December 9-13

  It was a particularly busy week in clinical trial news, largely because of the American Society of Hematology Annual Meeting. Here’s a look.

  December 13, 2019

   · 

  13 min read

   · 

  Mark Terry
• 

  FDA

  After August Rejection, FDA Approves Sarepta’s Vyondys 53 for Muscular Dystrophy

  The agency is requiring Sarepta to conduct a confirmatory trial, which Sarepta says will conclude by 2024.

  December 13, 2019

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Biogen’s Tau Antibody for Progressive Supranuclear Palsy Fails Trial

  The company indicated it is shutting down its gosuranemab program for PSP and other primary tauopathies.

  December 13, 2019

   · 

  3 min read

   · 

  Mark Terry
• 

  FDA

  FDA Action Alert: Correvio, Intra-Cellular and Amarin

  The U.S. Food and Drug Administration is wrapping up 2019 with a few PDUFA dates. Here’s a look.

  December 13, 2019

   · 

  3 min read

   · 

  Mark Terry
• 

  Career Advice

  Second, Third and Subsequent Interviews: How to Keep the Momentum Going

  The interview process at many organizations is not limited to a single interview. Multiple interviews are common and can occur for numerous reasons.

  December 13, 2019

   · 

  4 min read

   · 

  Katharine Hansen, PhD
• 

  Business

  Senate Confirms Stephen Hahn as Next FDA Commissioner

  The U.S. Senate confirmed Hahn as the new commissioner Thursday in a 72-18 vote.

  December 13, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  New Technology Could Help Treat Traumatic Brain Injury

  The technology leverages bio-manufactured exosomes.

  December 13, 2019

   · 

  3 min read

   · 

  Mark Terry